MaRS Innovation Staff Member Jackie Terry on Her Olympic Legacy
Olympians from all over the world are gathering today in London, England for the Opening Ceremony of the Games of the XXX Olympiad. For the thousands of athletes set to…
Olympians from all over the world are gathering today in London, England for the Opening Ceremony of the Games of the XXX Olympiad. For the thousands of athletes set to…
The Los Angeles Times featured Dr. Gregory Czarnota’s research in their Science Now section on July 10, 2012, which reports on discoveries from the world of science and medicine (update: the article is no longer available online).
Czarnota, a researcher at the Sunnybrook Health Sciences Centre, is working with MaRS Innovation to license his patented technology: radiosensitization of tumour cells using a combination of microbubbles and targeted, high-intensity, focused ultrasound.
Xagenic’s financing round to test platform and first diagnostic assay, continue product development and begin FDA submission Toronto, ON (December 2, 2013) — MaRS Innovation’s first start-up company, Xagenic Inc.,…
Mary Jo Haddad, President and CEO, has been inducted into the Canada’s Most Powerful Women: Top 100 Hall of Fame. Haddad received the Canada’s Most Powerful Women: Top 100 Award,…
Dr. Raphael Hofstein, president and CEO of MaRS Innovation, spoke to the Canadian International Council about the importance of protecting intellectual property as an important component in commercializing Canadian technologies.
Here’s an excerpt:
Government could be extremely helpful if they created special funds dedicated to covering the costs of patent protection.
MaRS Innovation provided crucial commercialization funding to support research from The Hospital for Sick Children MaRS Innovation (MI) and The Hospital for Sick Children (SickKids) have launched OtoSim Inc. to…